Modern Dental Group Limited (3600.HK)
- Previous Close
4.230 - Open
4.230 - Bid 4.120 x --
- Ask 4.140 x --
- Day's Range
4.110 - 4.160 - 52 Week Range
3.430 - 5.400 - Volume
47,000 - Avg. Volume
991,047 - Market Cap (intraday)
3.878B - Beta (5Y Monthly) 1.24
- PE Ratio (TTM)
9.60 - EPS (TTM)
0.430 - Earnings Date Mar 27, 2025
- Forward Dividend & Yield 0.18 (4.48%)
- Ex-Dividend Date Jun 3, 2025
- 1y Target Est
--
Modern Dental Group Limited, an investment holding company, engages in production, distribution, and trading of dental prosthetic devices in Europe, Greater China, North America, Australia, and internationally. The company operates through Fixed Prosthetic Devices, Removable Prosthetic Devices, and Others Devices segments. It offers restorative dental procedures, such as crowns, bridges, and implant. The company also produces full and partial dentures with and without metal frameworks. In addition, it offers orthodontic devices, sports guards, anti-snoring devices, raw materials, and dental equipment; and services for educational events and seminars. It sells its products under the Labocast, Modern Dental Laboratory, Quantum Dental Laboratory, Permadental, Elysee, Modern Dental Laboratory, Peak Dental Solutionsb, Yangzhijin Dental Laboratory, Pavona, Southern Cross Dental Laboratories, Micro Dental Laboratories, and Apex Digital Dental, and TrioClear brands. The company was founded in 1986 and is based in Cheung Sha Wan, Hong Kong.
www.moderndentalgp.com7,106
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: 3600.HK
View MorePerformance Overview: 3600.HK
Trailing total returns as of 5/8/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 3600.HK
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 3600.HK
View MoreValuation Measures
Market Cap
3.86B
Enterprise Value
3.97B
Trailing P/E
9.51
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.15
Price/Book (mrq)
1.42
Enterprise Value/Revenue
1.18
Enterprise Value/EBITDA
5.53
Financial Highlights
Profitability and Income Statement
Profit Margin
12.13%
Return on Assets (ttm)
9.01%
Return on Equity (ttm)
15.16%
Revenue (ttm)
3.36B
Net Income Avi to Common (ttm)
408M
Diluted EPS (ttm)
0.430
Balance Sheet and Cash Flow
Total Cash (mrq)
850.48M
Total Debt/Equity (mrq)
33.91%
Levered Free Cash Flow (ttm)
229.91M